Ying Yeoh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SINGAPORE, Nov. 3, 2022 /PRNewswire/ Oncoshot has just announced one of its biggest collaborations to date with Icon Cancer Centre in Singapore, alongside Roche. Together the partners plan to facilitate more comprehensive genomic profiling data to increase access to more trial options for cancer patients. This first-ever collaboration in SEA will help advance the biopharmaceutical research and development ecosystem for healthcare professionals, institutions and patients by taking a more personalised approach to care and offering people with cancer more treatment options. From left to right: Ying Ying Yeoh, General Manager of Roche Singapore; Serena Wee, CEO of Icon ASEAN and Hong Kong; Dr Huren Sivaraj, CEO and Co-Founder of Oncoshot. (Photography by Azfian Bin Anuar; editing by Mel Marc Cornelio) Presently, the cancer genomic testing process encompasses biological sampling from a patient, after which the test results are returned to the requesting doctor. Unless a doctor is aware of

Hong kongYing yeohHuren sivarajMel marc cornelioPrnewswire oncoshotRuslan enikeevIcon cancer centreGeneral managerRoche singaporeSerena weeAzfian bin anuarMedical oncologist dr huren sivarajData science engineer ruslanNov 3022 prnewswire oncoshot has just announced one of its biggest collaborations to date with icon cancer centre in singaporeLongside roche together the partners plan to facilitate more comprehensive genomic profiling data increase access trial options for cancer patients this first ever collaboration in sea will help advance biopharmaceutical research and development ecosystem healthcare professionals